Juliana Cabrini Carmello

Juliana Cabrini Carmello

Auto-generated profile, based on publicly available information

Juliana Cabrini Carmello

Universidade Estadual Paulista “Júlio de Mesquita Filho”, Brasil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2011 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
LDLívia Nordi Dovigo
Lívia Nordi Dovigo
APAna Claudia Pavarina
Ana Claudia Pavarina
JCJuliana C. Carmello
Juliana C. Carmello
AMAna Lucia Machado
Ana Lucia Machado
IBIguatemy Lourenço Brunetti
Iguatemy Lourenço Brunetti
VBVanderlei S. Bagnato
Vanderlei S. Bagnato

1 April 2013 in Medical Mycology
Verified
Journal Article
Closed access
LDLívia Nordi Dovigo
Lívia Nordi Dovigo
JCJuliana Cabrini Carmello
Juliana Cabrini Carmello
CCCarlos Alberto De Souza Costa
Carlos Alberto De Souza Costa
CVCarlos Eduardo Vergani
Carlos Eduardo Vergani
IBIguatemy Lourenço Brunetti
Iguatemy Lourenço Brunetti
APAna Claudia Pavarina
Ana Claudia Pavarina
In vitro investigations of curcumin-mediated photodynamic therapy (PDT) are encouraging, but there is a lack of reliable in vivo evidence of its efficacy. This study describes the photoinactivation of Candida albicans in a murine model of oral candidiasis, using curcumin as a photosensitizer. Forty immunosuppressed mice were orally inoculated with C. albicans and after five days, they received topical curcumin (20, 40 and 80 μM) and illumination with LED light. The use of curcumin or light alone were also investigated. Positive control animals did not receive any treatment and negative control animals were not inoculated with C. albicans. The number of surviving yeast cells was determined and analyzed by ANOVA and Tukey's post-hoc test (α = 0.05). Histological evaluation of the presence of yeast and inflammatory reaction was also conducted. All exposures to curcumin with LED light caused a significant reduction in C. albicans viability after PDT, but the use of 80 μM curcumin associated with light was able to induce the highest log10 reduction in colony counts (4 logs). It was concluded that curcumin-mediated PDT proved to be effective for in vivo inactivation of C. albicans without harming the host tissue of mice.

19 August 2018 in Molecules
Verified
Journal Article
Open access
PDF file
VSVinicius Sakima
Vinicius Sakima
PBPaula Aboud Barbugli
Paula Aboud Barbugli
PCPaulo Cerri
Paulo Cerri
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
JCJuliana Cabrini Carmello
Juliana Cabrini Carmello
Ewerton MimaEwerton Mima
Ewerton Mima
Antimicrobial photodynamic therapy (aPDT) has been proposed as an alternative method for oral candidiasis (OC), while nanocarriers have been used to improve the water solubility of curcumin (CUR). The aim of this study is to encapsulate CUR in polymeric nanoparticles (NPs) and to evaluate its photodynamic effects on a murine model of OC. Anionic and cationic CUR-NP is synthesized using poly-lactic acid and dextran sulfate and then characterized. Female mice are immunosuppressed and inoculated with Candida albicans (Ca) to induce OC. aPDT is performed by applying CUR-NP or free CUR on the dorsum of the tongue, followed by blue light irradiation for five consecutive days. Nystatin is used as positive control. Afterward, Ca are recovered and cultivated. Animals are euthanized for histological, immunohistochemical, and DNA damage evaluation. Encapsulation in NP improves the water solubility of CUR. Nystatin shows the highest reduction of Ca, followed by aPDT mediated by free CUR, which results in immunolabelling of cytokeratins closer to those observed for healthy animals. Anionic CUR-NP does not show antifungal effect, and cationic CUR-NP reduces Ca even in the absence of light. DNA damage is associated with Ca infection. Consecutive aPDT application is a safe treatment for OC.

2 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJuliana Cabrini Carmello
Juliana Cabrini Carmello
FAFernanda Alves
Fernanda Alves
FBFernanda G. Basso
Fernanda G. Basso
CCCarlos Alberto De Souza Costa
Carlos Alberto De Souza Costa
VBVanderlei Salvador Bagnato
Vanderlei Salvador Bagnato
APAna Claudia Pavarina
Ana Claudia Pavarina
This study evaluated the effectiveness of antimicrobial photodynamic therapy (aPDT) in the treatment of oral candidiasis in a murine model using Photodithazine® (PDZ). This model of oral candidiasis was developed to allow the monitoring of the infection and the establishment of the aPDT treatment. Six-week-old female mice were immunosuppressed and inoculated with C. albicans to induce oral candidiasis. PDZ-mediated aPDT and nystatin treatment were carried out for 5 consecutive days with one application per day. The macroscopic evaluation of oral lesions was performed. After each treatment, the tongue was swabbed to recover C. albicans cells. Viable colonies were quantified and the number of CFU/ml determined. The animals were sacrificed 24 hours and 7 days after treatment and the tongues were surgically removed for histological analysis and analysis of inflammatory cytokines expression (IL-1, TNF-α and IL-6) by RT-qPCR. Data were analyzed by two-way ANOVA. PDZ-mediated aPDT was as effective as Nystatin (NYS group) in the inactivation of C. albicans, reducing 3 and 3.2 logs10 respectively, 24 h after treatment (p<0.05). Animals underwent PDZ-mediated aPDT showed complete remission of oral lesions, while animals treated with NYS presented partial remission of oral lesions in both periods assessed. Histological evaluation revealed mild inflammatory infiltrate in the groups treated with aPDT and NYS in both periods assessed. The aPDT induced the TNF-α expression when compared with the control (P-L-) (p<0.05), 24 h and 7 days after treatment. In summary, the murine model developed here was able to mimic the infection and PDZ-mediated aPDT was effective to treat mice with oral candidiasis.

12 September 2013 in Biofouling
Verified
Journal Article
Closed access
LDLívia Nordi Dovigo
Lívia Nordi Dovigo
JCJ.C. Carmello
J.C. Carmello
MCM.T. Carvalho
M.T. Carvalho
Ewerton MimaEwerton Mima
Ewerton Mima
CVC.E. Vergani
C.E. Vergani
APAna Claudia Pavarina
Ana Claudia Pavarina
This study evaluated the photodynamic inactivation (PDI) mediated by Photodithazine® (PDZ) against 15 clinical isolates of Candida albicans, Candida glabrata and Candida tropicalis. Each isolate, in planktonic and biofilm form, was exposed to PDI by assessing a range of PDZ concentrations and light emitting diode fluences. Cell survival of the planktonic suspensions was determined by colony forming units (CFU ml−1). The antifungal effects of PDI against biofilms were evaluated by CFU ml−1 and metabolic assay. Data were analyzed by non-parametric tests (α = 0.05). Regardless of the species, PDI promoted a significant viability reduction of planktonic yeasts. The highest reduction in cell viability of the biofilms was equivalent to 0.9 log10 (CFU ml−1) for C. albicans, while 1.4 and 1.5 log10 reductions were obtained for C. tropicalis and C. glabrata, respectively. PDI reduced the metabolic activity of biofilms by 62.1, 76.0, and 76.9% for C. albicans, C. tropicalis, and C. glabrata, respectively. PDZ-mediated PDI promoted significant reduction in the viability of Candida isolates.

3 August 2013 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
CQCristiane Campos Costa Quishida
Cristiane Campos Costa Quishida
JCJuliana Cabrini Carmello
Juliana Cabrini Carmello
Ewerton MimaEwerton Mima
Ewerton Mima
VBVanderlei Salvador Bagnato
Vanderlei Salvador Bagnato
AMAna Lucia Machado
Ana Lucia Machado
APAna Claudia Pavarina
Ana Claudia Pavarina